Results 81 to 90 of about 4,466 (100)

[Prognostic analysis of 19 newly treated multiple myeloma patients with t(14; 16)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Li Y, Liu JR, Li J, Chen WM.
europepmc   +1 more source

[Effects and mechanisms of the kidney-reinforcing and blood circulation-activating and collateral dredging decoction metabolites on the proliferation of multiple myeloma KM3 cells]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Shi JB, Li CN, Wei WJ, Ding JY, Ma GD, Li LL, Wang YR, Lu YT, Xu J, Zheng W, Wang Y, Wang JY, Xu RR, Cui SY.   +13 more
europepmc   +1 more source

Clinical significance of CD45 and CD200 expression in newly diagnosed multiple myeloma patients. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Long X, Liu J, Hu R, Wang C, Fu Y.
europepmc   +1 more source

[The Chinese clinical expert consensus for the BCMA bispecific T cell engager in the treatment of multiple myeloma (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Chinese Hematology Association, Chinese Myeloma Committee, Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Geriatrics Association, Society of Hematology.   +6 more
europepmc   +1 more source

[Expert consensus on the comprehensive management of monoclonal gammopathy of undetermined significance and smoldering multiple myeloma in China (2025)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Plasma Cell Disease Group, Chinese Society of Hematology, Chinese Medical Association, Chinese Myeloma Committee-Chinese Hematology Association.   +3 more
europepmc   +1 more source

[Minimal residual disease assessment and progress in multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Zhou HX, Chen WM.
europepmc   +1 more source

[Expression and clinical significance of CCL17, CCL22, and CCR4 in newly diagnosed multiple myeloma]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Xiao ZF, Zou SS, Yi CF, Zhao Y, Wu LS, Feng YH.   +5 more
europepmc   +1 more source

[Chinese expert consensus on diagnosis and treatment of high risk multiple myeloma (2024)]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Myeloma & Plasma Cell Disease Group, Hematology Oncology Committee of China Anti-Cancer Association;, Multiple Myeloma Expert Committee of Chinese Society of Clinical Oncology.   +2 more
europepmc   +1 more source

[Detection of cytogenetic abnormalities in multiple myeloma by using optical genome mapping]. [PDF]

Zhonghua Xue Ye Xue Za Zhi
Wang YF, Zhang ZH, Wang H, Xi LY, Dong F, Jing HM.   +5 more
europepmc   +1 more source